DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Virtual Booth

Contact Supplier

Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: D-3-methoxy-4-hydroxyphenylglycol, (-)-4-hydroxy-3-methoxyphenylglycol, D-(-)-3-methoxy-4-hydroxyphenylglycol, 3-methoxy-4-hydroxyphenylglycol, (-)-, Z02b4y02fv, 87171-18-4

Molecular Formula

C₉H₁₂O₄

Molecular Weight

184.19 g/mol

InChI Key

FBWPWWWZWKPJFL-QMMMGPOBSA-N

FDA UNII

Z02B4Y02FV

Synthesized from endogenous epinephrine and norepinephrine in vivo. It is found in brain, blood, CSF, and urine, where its concentrations are used to measure catecholamine turnover.

1 2D Structure

87171-18-4

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

(1R)-1-(4-hydroxy-3-methoxyphenyl)ethane-1,2-diol

2.1.2 InChI

InChI=1S/C9H12O4/c1-13-9-4-6(8(12)5-10)2-3-7(9)11/h2-4,8,10-12H,5H2,1H3/t8-/m0/s1

2.1.3 InChI Key

FBWPWWWZWKPJFL-QMMMGPOBSA-N

2.1.4 Canonical SMILES

COC1=C(C=CC(=C1)C(CO)O)O

2.1.5 Isomeric SMILES

COC1=C(C=CC(=C1)[C@H](CO)O)O

2.2 Other Identifiers

2.2.1 UNII

Z02B4Y02FV

2.3 Synonyms

2.3.1 MeSH Synonyms

1. 4 Hydroxy 3 Methoxyphenylethylene Glycol

2. 4 Hydroxy 3 Methoxyphenylethyleneglycol

3. 4 Hydroxy 3 Methoxyphenylglycol

4. 4-hydroxy-3-methoxyphenylethylene Glycol

5. 4-hydroxy-3-methoxyphenylethyleneglycol

6. 4-hydroxy-3-methoxyphenylglycol

7. Hydroxymethoxyphenylglycol

8. Methoxyhydroxyphenylglycol

9. Methoxyhydroxyphenylglycol, (+)-isomer

10. Methoxyhydroxyphenylglycol, (+-)-isomer

11. Methoxyhydroxyphenylglycol, (-)-isomer

12. Mhpg

13. Mopeg

14. Vanylglycol

2.3.2 Depositor-Supplied Synonyms

1. D-3-methoxy-4-hydroxyphenylglycol

2. (-)-4-hydroxy-3-methoxyphenylglycol

3. D-(-)-3-methoxy-4-hydroxyphenylglycol

4. 3-methoxy-4-hydroxyphenylglycol, (-)-

5. Z02b4y02fv

6. 87171-18-4

7. (r)-1-(4-hydroxy-3-methoxyphenyl)ethane-1,2-diol

8. 1,2-ethanediol, 1-(4-hydroxy-3-methoxyphenyl)-, (1r)-

9. 4-hydroxy-3-methoxyphenylglycol

10. Unii-z02b4y02fv

11. Methoxy-hydroxyphenyl Glycol

12. Zinc56460

13. (-)-3-methoxy-4-hydroxyphenylglycol

14. (r)-1-(3-methoxy-4-hydroxyphenyl)-1,2-ethanediol

15. Q27294817

16. Droxidopa Metabolite (3-methoxy-4-hydroxyphenylglycol, (-)-)

2.4 Create Date

2005-07-07

3 Chemical and Physical Properties

Molecular Formula	C₉H₁₂O₄
Molecular Weight	184.19 g/mol
XLogP3	-0.7
Hydrogen Bond Donor Count	3
Hydrogen Bond Acceptor Count	4
Rotatable Bond Count	3
Exact Mass	184.07355886 g/mol
Monoisotopic Mass	184.07355886 g/mol
Topological Polar Surface Area	69.9 Å²
Heavy Atom Count	13
Formal Charge	0
Complexity	151
Isotope Atom Count	0
Defined Atom Stereocenter Count	1
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1

ABOUT THIS PAGE

Find 87171-18-4 manufacturers, exporters & distributors on PharmaCompass

87171-18-4

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

PATENTS & EXCLUSIVITIES

DIGITAL CONTENT

GLOBAL SALES INFORMATION

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

What are you looking for?